| Gaps in optimal care for lung cancer. | |
| | |
MedLine Citation:
|
PMID: 18670305 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
PURPOSE: Lung cancer is the leading cause of cancer death in Australia, but little is known about how Australian patients with this disease are managed. METHODS: Lung cancer patients diagnosed from November 1, 2001 to December 31, 2002 were identified through the population-based New South Wales Central Cancer Registry. Information was collected on diagnosis, staging, referrals, and treatment. Cross-tabulations and logistic regression examined factors related to not receiving cancer-specific therapy. RESULTS: There were 2931 potentially eligible patients registered by the Central Cancer Registry and completed questionnaires were obtained for 1812 patients (62%); median age 71 years and 66% men. The pathology was non-small cell in 71%, small cell in 15% and not confirmed in 13% of patients. Eleven percent of patients did not see a lung cancer specialist and 33% received no cancer-specific therapy after initial diagnosis. Treatment utilization rates were 17% for surgery, 39% for radiotherapy, and 30% for chemotherapy. Factors significantly associated with having no cancer-specific therapy included female gender, older age, weight loss, poorer performance status, advanced or unknown disease stage, and consultation with a low patient volume lung cancer specialist or a non-lung cancer specialist. The median survival was 172 days and 2-year crude survival was 17%. CONCLUSIONS: Treatment patterns were in broad concordance with present national guidelines. Nevertheless, a significant proportion of lung cancer patients did not receive cancer-specific therapy. Treatment decisions should be multidisciplinary and decision-makers should include experienced lung cancer specialists. |
| | |
Authors:
|
Shalini K Vinod; Dianne L O'Connell; Leonardo Simonella; Geoff P Delaney; Michael Boyer; Matthew Peters; Danielle Miller; Rajah Supramaniam; Leslie McCawley; Bruce Armstrong |
Related Documents
:
|
18707825 - Patterns of care for lung cancer in radiation oncology departments of turkey. 20658535 - Importin subunit alpha-2 is identified as a potential biomarker for non-small cell lung... 17525835 - Overexpression of rhoe has a prognostic value in non-small cell lung cancer. 9516605 - Autocrine growth factors and neuroendocrine markers in the development of small-cell lu... 20099495 - Plasma concentration of angiopoietin-1, angiopoietin-2 and tie-2 in cervical cancer. 17919355 - Post-traumatic growth in advanced cancer patients receiving palliative care. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer Volume: 3 ISSN: 1556-1380 ISO Abbreviation: J Thorac Oncol Publication Date: 2008 Aug |
Date Detail:
|
Created Date: 2008-08-01 Completed Date: 2008-11-25 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101274235 Medline TA: J Thorac Oncol Country: United States |
Other Details:
|
Languages: eng Pagination: 871-9 Citation Subset: IM |
Affiliation:
|
Collaboration for Cancer Outcomes, Research and Evaluation (CCORE), University of New South Wales, Liverpool Hospital, Liverpool BC, New South Wales, Australia. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult Aged Aged, 80 and over Carcinoma, Non-Small-Cell Lung / mortality, pathology, therapy* Carcinoma, Small Cell / mortality, pathology, therapy* Child Child, Preschool Delivery of Health Care / standards* Female Humans Infant Infant, Newborn Lung Neoplasms / mortality, pathology, therapy* Male Middle Aged Neoplasm Staging Patient Care Team / standards* Practice Guidelines as Topic Quality of Health Care Questionnaires Registries Survival Rate Young Adult |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Waiting times in early-stage non-small cell lung cancer (NSCLC).
Next Document: Prognostic significance of the number of lymph nodes removed at lobectomy in stage IA non-small cell...